Medtech Archives - Page 8 of 113 - Boston Life Sciences Times

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

THIS WEEK'S STORIES

Inflammasome Therapeutics to Partner with Healey & AMG Center for ALS on New ALS Treatment Trial

November 13, 2025

Aldeyra Therapeutics Expands RASP Platform to Central Nervous System Diseases and Shares Updates on Reproxalap Manufacturing

November 13, 2025

Neochromosome and GlobalBio Introduce Pre-Transformed Antibody Libraries on Switchable Yeast Platform

November 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

VenstraMedical Secures Investment From Highcroft Capital to Advance Next-Generation Cardiac Support Device

Sempresto Acquires Third Autoinjector Platform to Advance Smartphone-Integrated Rescue Medication Technology

CurvaFix Expands National Market Access with Premier Inc. Breakthrough Designation for Orthopedic Trauma Products

VahatiCor Closes Oversubscribed Series B to Accelerate A-FLUX Development for Coronary Microvascular Dysfunction

Cognision Partners with Kynexis to Use COGNISION System in Phase 2 Trial of KYN-5356 for Schizophrenia

Most Read

VenstraMedical Secures Investment From Highcroft Capital to Advance Next-Generation Cardiac Support Device

Profluent Raises $106 Million to Scale Frontier AI Models for Programmable Biology

Synthio Labs Raises $5 Million to Build Voice AI Operating System for Life Sciences Engagement

AI Proteins Raises $41.5 Million Series A to Advance De Novo Miniprotein Medicines

EDITOR PICKS

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

THIS WEEK'S STORIES

Inflammasome Therapeutics to Partner with Healey & AMG Center for ALS on New ALS Treatment Trial

Aldeyra Therapeutics Expands RASP Platform to Central Nervous System Diseases and Shares Updates on Reproxalap Manufacturing

Neochromosome and GlobalBio Introduce Pre-Transformed Antibody Libraries on Switchable Yeast Platform

POPULAR CATEGORY

ABOUT US

FOLLOW US